Back to top

Becton, Dickinson and Company (BDX)

(Delayed Data from NYSE)

$255.31 USD


+1.83 (0.72%)

Updated Jul 29, 2021 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.57%
5Strong Sell3.16%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (89 out of 252)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Zacks News

Based in Franklin Lakes, NJ, Becton, Dickinson and Company (BDX) commonly known as BD, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. In fiscal 2019, BD’s revenues increased 8.2% to $17.29 billion. Earlier, BD’s operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. However, the company’s organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional.

Becton Dickinson (BDX) Reports Next Week: Wall Street Expects Earnings Growth

Becton Dickinson (BDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Add Teleflex (TFX) to Your Portfolio

Strong segmental performance in America and Asia is driving the top line for Teleflex (TFX).

Trina Mukherjee headshot

3 Stocks to Tap the Promising Dental Supplies Industry

Despite the COVID-19 pandemic induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical-Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.

Sheraz Mian headshot

Q2 Earnings Scorecard & Analyst Reports for Microsoft, AbbVie & Enbridge

We have provided a real-time scorecard of the Q2 earnings season, in addition to featuring Microsoft (MSFT), AbbVie (ABBV), Enbridge (ENB) and other stocks.

BD's (BDX) Digital Marketplace Set to Improve User Experience

BD's (BDX) latest online marketplace is expected to offer a better user experience to its flow cytometry users.

Trina Mukherjee headshot

Grab these 3 MedTech Stocks That Outperformed S&P 500 YTD

Snap up these three top stocks, WST, PAHC and RMD, which continue to show promise amid the pandemic and can turn out to be prudent investment choices.

Trina Mukherjee headshot

3 Best MedTech Growth Stocks to Bet On in 2021 Amid Pandemic

Grab these three top stocks, EYE, WST and HSIC, which continue to show promise amid the pandemic and can turn out to be wise investment choices for 2021.

BD's (BDX) PeritX System Gets FDA's Expanded 510(k) Clearance

BD's (BDX) receipt of the expanded FDA indication for its PeritX System is expected to lessen the number of hospital trips a patient takes for fluid removal.

Debanjana Dey headshot

Cardiology Space Gains Momentum in 2021: 5 Stocks to Focus on

These cardiology device stocks Medtronic (MDT), Boston Scientific (BSX), Edwards Lifesciences (EW), Merit Medical (MMSI), BD (BDX) are expected to continue their run over the next few months.

Trina Mukherjee headshot

Cybersecurity Gains Prominence in Healthcare: 3 Stocks to Watch

Here we look at three stocks, VEEV, HSIC and BDX, that investors can keep a watch on the back of their robust cybersecurity measures.

BD's (BDX) Rapid COVID-19 Test for US Olympic Trial Swimmers

BD (BDX) to provide rapid antigen testing for COVID-19 at the U.S. Olympic Team Trials and other competitive swimming events on behalf of USA Swimming.

BD's (BDX) Milestone Pandemic Orders to Support Vaccinations

BD (BDX) receives 2 billion pandemic orders for needles and syringes to support global COVID-19 vaccination efforts.

BD (BDX) Solidifies Foothold in Healthcare Cybersecurity

BD's (BDX) authorization as a CNA is expected to allow it to provide customers with timely information about vulnerabilities in BD products available globally.

BD (BDX) to Boost Lab Efficacy With BD Kiestra UCA's U.S. Launch

BD's (BDX) UCA leverages AI to revolutionize the way microbiology labs conduct urine culture analysis.

Hologic (HOLX) ThinPrep Genesis Processor Gets FDA Approval

Hologic's (HOLX) ThinPrep Genesis processor offers new automation capabilities and workflow enhancements.

BD's (BDX) First Self-Collection HPV Screening Assay Gets CE Mark

BD's (BDX) industry-first CE marked self-collection claim for HPV screening enables greater access to testing for women.

Becton Dickinson (BDX) Earnings Surpass Estimates in Q2

Each of Becton Dickinson's (BDX) core units witnesses strong revenue growth in the fiscal second quarter.

National Vision (EYE) to Report Q1 Earnings: What's in Store?

National Vision's (EYE) transitions of five additional Walmart Vision Centers in 2020, which have become operative of late, are expected to post positive Q1 results.

GoodRx (GDRX) to Report Q1 Earnings: What's in the Offing?

GoodRx' (GDRX) manufacturer solutions offerings continue to grow at a strong rate, registering record bookings over the past months.

Becton Dickinson (BDX) Tops Q2 Earnings and Revenue Estimates

Becton Dickinson (BDX) delivered earnings and revenue surprises of 4.93% and 1.47%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Why Earnings Season Could Be Great for Becton, Dickinson (BDX)

Becton, Dickinson (BDX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Cardinal Health (CAH) to Post Q3 Earnings: What's in Store?

Cardinal Health's (CAH) fiscal third-quarter results are likely to reflect solid performance in Pharmaceutical segment.

DENTSPLY SIRONA (XRAY) to Post Q1 Earnings: What's in Store?

DENTSPLY SIRONA's (XRAY) first-quarter results are likely to reflect weak segmental performance.

BD (BDX) Gears Up for Q2 Earnings: What's in the Offing?

BD's (BDX) second-quarter fiscal 2021 results are likely to reflect strong year-over-year growth in revenues from assays in its Life Sciences segment.

Becton Dickinson (BDX) Earnings Expected to Grow: Should You Buy?

Becton Dickinson (BDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.